Market Place
Sourcing Support
Arctic Vision Announces the Acceptance in Australia of NDA for Suprachoroidal Use of Arcatus
10 Jul 2023 //
GLOBENEWSWIRE
Arctic Vision Begins Enrollment in PIII Trial of ARVN003 for Presbyopia
04 Jul 2022 //
ASIAONE
Arctic Vision Begins Dosing in Phase III Study of ARVN001 for UME
22 Nov 2021 //
PRNEWSWIRE
Arctic Vision Announces Addition of MydCombi to Eyenovia Commercialization Deal
16 Sep 2021 //
PRNEWSWIRE
Clearside Biomedical Expands XIPERE License Agreement with Arctic Vision
09 Sep 2021 //
GLOBENEWSWIRE
NMPA clears Arctic Vision’s IND for phase III study of ARVN003 in presbyopia
04 Sep 2021 //
PHARMABIZ
Arctic Vision expands licensing for ARVN001 to ASEAN countries & India.
17 Aug 2021 //
PHARMABIZ
Innovent`s Sintilimab in Combination with Chemotherapy Meets Primary Endpoint
15 Aug 2021 //
PR NEWSWIRE
Arctic Vision inks pact with University of Hong Kong Department of Ophthalmology
06 Jul 2021 //
PHARMABIZ
Arctic Vision Announces Exclusive Licensing Agreement With ActualEyes
14 May 2021 //
NEWS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.